Cibc Asset Management Inc Jazz Pharmaceuticals PLC Transaction History

Cibc Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$115.19 - $132.77 $460 - $531	4 Added 0.19%	2,124 $255,000
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $16,453 - $19,584	-144 Reduced 6.36%	2,120 $260,000
Q3 2023 Oct 30, 2023	BUY	$122.0 - $145.31 $14,762 - $17,582	121 Added 5.65%	2,264 $293,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $245 - $294	2 Added 0.09%	2,143 $265,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $286,851 - $343,566	2,141 New	2,141 $313,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.99B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.